{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Lets See How The Disc Models Preformed"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "This notebook is designed to analyze the disc models performance and to answer the question does Long Short Term Memory Neural Net (LSTM) outperform SparseLogisticRegression (SLR)."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## MUST RUN AT THE START OF EVERYTHING"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Load the database and other helpful functions for analysis."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "%load_ext autoreload\n",
    "%autoreload 2\n",
    "%matplotlib inline\n",
    "\n",
    "import csv\n",
    "import os\n",
    "\n",
    "from IPython.core.display import display, HTML\n",
    "import matplotlib.pyplot as plt\n",
    "import numpy as np\n",
    "import re\n",
    "import pandas as pd\n",
    "import seaborn as sns\n",
    "from sklearn.metrics import average_precision_score, precision_recall_curve, roc_curve, auc, f1_score, confusion_matrix\n",
    "import tqdm"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "#Set up the environment\n",
    "username = \"danich1\"\n",
    "password = \"snorkel\"\n",
    "dbname = \"pubmeddb\"\n",
    "\n",
    "#Path subject to change for different os\n",
    "database_str = \"postgresql+psycopg2://{}:{}@/{}?host=/var/run/postgresql\".format(username, password, dbname)\n",
    "os.environ['SNORKELDB'] = database_str\n",
    "\n",
    "from snorkel import SnorkelSession\n",
    "session = SnorkelSession()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "from snorkel.annotations import FeatureAnnotator, LabelAnnotator, load_marginals\n",
    "from snorkel.learning import SparseLogisticRegression\n",
    "from snorkel.learning.disc_models.rnn import reRNN\n",
    "from snorkel.learning.utils import RandomSearch\n",
    "from snorkel.models import Candidate, FeatureKey, candidate_subclass\n",
    "from snorkel.utils import get_as_dict\n",
    "from snorkel.viewer import SentenceNgramViewer\n",
    "from sqlalchemy import and_\n",
    "from tree_structs import corenlp_to_xmltree\n",
    "from treedlib import compile_relation_feature_generator"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "edge_type = \"dg\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "if edge_type == \"dg\":\n",
    "    DiseaseGene = candidate_subclass('DiseaseGene', ['Disease', 'Gene'])\n",
    "elif edge_type == \"gg\":\n",
    "    GeneGene = candidate_subclass('GeneGene', ['Gene1', 'Gene2'])\n",
    "elif edge_type == \"cg\":\n",
    "    CompoundGene = candidate_subclass('CompoundGene', ['Compound', 'Gene'])\n",
    "elif edge_type == \"cd\":\n",
    "    CompoundDisease = candidate_subclass('CompoundDisease', ['Compound', 'Disease'])\n",
    "else:\n",
    "    print(\"Please pick a valid edge type\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Load the data"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Here is where we load the test dataset in conjunction with the previously trained disc models. Each algorithm will output a probability of a candidate being a true candidate."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "labeler = LabelAnnotator(lfs=[])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "3830137it [00:15, 252642.23it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "CPU times: user 7.24 s, sys: 300 ms, total: 7.54 s\n",
      "Wall time: 19.4 s\n"
     ]
    }
   ],
   "source": [
    "%%time\n",
    "L_test = labeler.load_matrix(session,split=2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(370179, 1)"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "L_test.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "model_marginals = pd.read_csv(\"stratified_data/lstm_disease_gene_holdout/lstm_one_percent.csv\")\n",
    "model_marginals[\"True_Labels\"] = L_test.todense()\n",
    "model_marginals[\"RNN_1_Predictions\"] = model_marginals[\"RNN_marginals\"].apply(lambda x: 1 if x > 0.5 else -1)\n",
    "model_marginals = model_marginals.rename(index=str, columns={\"RNN_marginals\":\"RNN_1_Marginals\"})\n",
    "model_marginals[\"RNN_10_Marginals\"] = pd.read_csv(\"stratified_data/lstm_disease_gene_holdout/lstm_ten_percent.csv\").values\n",
    "model_marginals[\"RNN_10_Predictions\"] = model_marginals[\"RNN_10_Marginals\"].apply(lambda x: 1 if x > 0.5 else -1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "test_set = pd.read_csv(\"stratified_data/lstm_disease_gene_holdout/test_candidates_sentences.csv\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Accuracy ROC"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "From the probabilities calculated above, we can create a [Receiver Operator Curve](http://scikit-learn.org/stable/auto_examples/model_selection/plot_roc.html) (ROC) graph to measure the false positive rate and the true positive rate at each calculated threshold."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.legend.Legend at 0x7f45551e0a90>"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAe8AAAFnCAYAAACPasF4AAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\nuQAAAABJRU5ErkJggg==\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7f45551e0610>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "models = [\"RNN_1_Marginals\", \"RNN_10_Marginals\"]\n",
    "model_colors = [\"green\", \"magenta\"]\n",
    "model_labels = [\"RNN_1%\", \"RNN_10%\"]\n",
    "plt.plot([0, 1], [0, 1], color='navy', lw=2, linestyle='--')\n",
    "\n",
    "for model_label, marginal_label, color in zip(model_labels, models, model_colors):\n",
    "    fpr, tpr, _= roc_curve(model_marginals[\"True_Labels\"], model_marginals[marginal_label])\n",
    "    model_auc = auc(fpr, tpr)\n",
    "    plt.plot(fpr, tpr, color=color, label=\"{} (area = {:0.2f})\".format(model_label, model_auc))\n",
    "\n",
    "plt.xlabel('False Positive Rate')\n",
    "plt.ylabel('True Positive Rate')\n",
    "plt.title('Accuracy ROC')\n",
    "plt.legend(loc=\"lower right\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Precision vs Recall Curve"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "This code produces a [Precision-Recall](http://scikit-learn.org/stable/auto_examples/model_selection/plot_precision_recall.html) graph, which shows the trade off between [precision and recall](https://en.wikipedia.org/wiki/Precision_and_recall) at each given probability threshold."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {
    "scrolled": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.legend.Legend at 0x7f45471393d0>"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAfIAAAFnCAYAAABdOssgAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7f4554f14050>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "models = [\"RNN_1_Marginals\", \"RNN_10_Marginals\"]\n",
    "model_colors = [\"green\", \"magenta\"]\n",
    "model_labels = [\"RNN_1%\", \"RNN_10%\"]\n",
    "\n",
    "\n",
    "for model_label, marginal_label, color in zip(model_labels, models, model_colors):\n",
    "    precision, recall, _ = precision_recall_curve(model_marginals[\"True_Labels\"], model_marginals[marginal_label])\n",
    "    model_precision = average_precision_score(model_marginals[\"True_Labels\"], model_marginals[marginal_label])\n",
    "    plt.plot(recall, precision, color=color, label=\"{} curve (area = {:0.2f})\".format(model_label, model_precision))\n",
    "\n",
    "plt.ylabel('Precision')\n",
    "plt.xlabel('Recall')\n",
    "plt.title('Precision vs Recall')\n",
    "plt.xlim([0, 1.01])\n",
    "plt.ylim([0, 1.05])\n",
    "plt.legend(loc=\"lower right\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {
    "scrolled": false
   },
   "outputs": [
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAeAAAAFnCAYAAAB+YZr1AAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\n/wdZTq8xVYiDpgAAAABJRU5ErkJggg==\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7f4554f148d0>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAeAAAAFnCAYAAAB+YZr1AAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\nqwAAAABJRU5ErkJggg==\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7f4552331890>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "for model in [\"RNN_1_Predictions\", \"RNN_10_Predictions\"]:\n",
    "    matrix = confusion_matrix(model_marginals[\"True_Labels\"], model_marginals[model])\n",
    "    chart1, ax1 = plt.subplots()\n",
    "    plt.title(model)\n",
    "    ax = sns.heatmap(matrix, annot=True, fmt=\"d\", cmap=\"BuGn\", xticklabels=[\"No\",\"Yes\"], yticklabels=[\"No\", \"Yes\"], ax=ax1)\n",
    "    ax.set_xlabel(\"Predicted Labels\")\n",
    "    ax.set_ylabel(\"True Labels\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## LSTM Model Analysis"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style>\n",
       "    .dataframe thead tr:only-child th {\n",
       "        text-align: right;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: left;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>RNN_1_Marginals</th>\n",
       "      <th>True_Labels</th>\n",
       "      <th>RNN_1_Predictions</th>\n",
       "      <th>RNN_10_Marginals</th>\n",
       "      <th>RNN_10_Predictions</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>326461</th>\n",
       "      <td>0.097094</td>\n",
       "      <td>-1</td>\n",
       "      <td>-1</td>\n",
       "      <td>0.959252</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>339482</th>\n",
       "      <td>0.330033</td>\n",
       "      <td>-1</td>\n",
       "      <td>-1</td>\n",
       "      <td>0.958792</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4152</th>\n",
       "      <td>0.086697</td>\n",
       "      <td>-1</td>\n",
       "      <td>-1</td>\n",
       "      <td>0.957856</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>131170</th>\n",
       "      <td>0.075546</td>\n",
       "      <td>-1</td>\n",
       "      <td>-1</td>\n",
       "      <td>0.955985</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>366585</th>\n",
       "      <td>0.224695</td>\n",
       "      <td>-1</td>\n",
       "      <td>-1</td>\n",
       "      <td>0.955359</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>341508</th>\n",
       "      <td>0.085870</td>\n",
       "      <td>-1</td>\n",
       "      <td>-1</td>\n",
       "      <td>0.950881</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16535</th>\n",
       "      <td>0.072002</td>\n",
       "      <td>-1</td>\n",
       "      <td>-1</td>\n",
       "      <td>0.950477</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>245186</th>\n",
       "      <td>0.929363</td>\n",
       "      <td>-1</td>\n",
       "      <td>1</td>\n",
       "      <td>0.949889</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15567</th>\n",
       "      <td>0.426900</td>\n",
       "      <td>-1</td>\n",
       "      <td>-1</td>\n",
       "      <td>0.949888</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>299413</th>\n",
       "      <td>0.081357</td>\n",
       "      <td>-1</td>\n",
       "      <td>-1</td>\n",
       "      <td>0.949350</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "        RNN_1_Marginals  True_Labels  RNN_1_Predictions  RNN_10_Marginals  \\\n",
       "326461         0.097094           -1                 -1          0.959252   \n",
       "339482         0.330033           -1                 -1          0.958792   \n",
       "4152           0.086697           -1                 -1          0.957856   \n",
       "131170         0.075546           -1                 -1          0.955985   \n",
       "366585         0.224695           -1                 -1          0.955359   \n",
       "341508         0.085870           -1                 -1          0.950881   \n",
       "16535          0.072002           -1                 -1          0.950477   \n",
       "245186         0.929363           -1                  1          0.949889   \n",
       "15567          0.426900           -1                 -1          0.949888   \n",
       "299413         0.081357           -1                 -1          0.949350   \n",
       "\n",
       "        RNN_10_Predictions  \n",
       "326461                   1  \n",
       "339482                   1  \n",
       "4152                     1  \n",
       "131170                   1  \n",
       "366585                   1  \n",
       "341508                   1  \n",
       "16535                    1  \n",
       "245186                   1  \n",
       "15567                    1  \n",
       "299413                   1  "
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "condition = (model_marginals[\"RNN_10_Predictions\"] == 1)&(model_marginals[\"True_Labels\"] == -1)\n",
    "indicies = set(model_marginals[condition].sort_values(\"RNN_10_Marginals\", ascending=False).index)\n",
    "model_marginals[condition].sort_values(\"RNN_10_Marginals\", ascending=False).head(10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "def insert(x, g_start, g_end, d_start, d_end, proba, d_cid, g_cid):\n",
    "    if d_start == x[0] or g_start == x[0]:\n",
    "        pos_str = \"<span title=\\\"{}\\\" style=\\\"background-color: rgba(0,255,0,{})\\\">{}\"\n",
    "        neg_str = \"<span title=\\\"{}\\\" style=\\\"background-color: rgba(255,0,0,{})\\\">{}\"\n",
    "        if proba > 0.5:\n",
    "            return pos_str.format(d_cid, proba, x[1]) if d_start == x[0] else pos_str.format(g_cid, proba, x[1])\n",
    "        else:\n",
    "            return neg_str.format(d_cid, 1-proba, x[1]) if d_start == x[0] else neg_str.format(g_cid, 1-proba, x[1])\n",
    "    elif d_end == x[0] or g_end == x[0]:\n",
    "            return \"{}</span>\".format(x[1])\n",
    "    else:\n",
    "        return x[1]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Look at the Sentences and the LSTM's predictions"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "199it [00:01, 106.16it/s]\n"
     ]
    }
   ],
   "source": [
    "html_string = \"\"\n",
    "counter = 0\n",
    "condition = (model_marginals[\"RNN_10_Predictions\"] == 1)&(model_marginals[\"True_Labels\"] == -1)\n",
    "for marginal in tqdm.tqdm(model_marginals[condition].itertuples()):\n",
    "    cand = test_set.iloc[int(marginal[0])]\n",
    "    \n",
    "    counter += 1\n",
    "    \n",
    "    if counter == 200:\n",
    "        break\n",
    "        \n",
    "    if counter > 0:\n",
    "        gene_start = cand[\"gene_char_start\"]\n",
    "        gene_end = cand[\"gene_char_end\"]\n",
    "        disease_start = cand[\"disease_char_start\"]\n",
    "        disease_end = cand[\"disease_char_end\"]\n",
    "        proba = marginal[4]\n",
    "        letters = []\n",
    "\n",
    "        for x in enumerate(cand[\"sentence\"]):\n",
    "            letters.append(insert(x, gene_start, gene_end, disease_start, disease_end, proba, cand[\"disease_id\"], cand[\"gene_id\"]))\n",
    "\n",
    "        html_string += \"<div title=\\\"{}\\\">{}</div><br />\".format(proba, ''.join(letters))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<html>\n",
       "<head>\n",
       "</head>\n",
       "<body>\n",
       "<div title=\"0.825412690639\">the <span title=\"1846\" style=\"background-color: rgba(0,255,0,0.825412690639)\">PAS-Typ</span> (<span title=\"DOID:2531\" style=\"background-color: rgba(0,255,0,0.825412690639)\">acute undifferenciated leukemia) paramyeloblastic leukemia</span>, 2.</div><br /><div title=\"0.913339316845\">Variation of blood glucose and serum growth hormone, <span title=\"5617\" style=\"background-color: rgba(0,255,0,0.913339316845)\">prolactin</span> and insulin in subjects with <span title=\"DOID:9744\" style=\"background-color: rgba(0,255,0,0.913339316845)\">insulin-dependent diabetes</span>, after OGTT and pretreatment with 2-Br-alpha-ergocryptine.</div><br /><div title=\"0.90477180481\"><span title=\"23209\" style=\"background-color: rgba(0,255,0,0.90477180481)\">MLC-activation</span> by <span title=\"DOID:2531\" style=\"background-color: rgba(0,255,0,0.90477180481)\">acute lymphatic leukemia blasts</span>.</div><br /><div title=\"0.859962940216\">Stimulation of <span title=\"23209\" style=\"background-color: rgba(0,255,0,0.859962940216)\">MLC</span> and <span title=\"DOID:2531\" style=\"background-color: rgba(0,255,0,0.859962940216)\">CML</span> by human T cells.</div><br /><div title=\"0.926470160484\"><span title=\"DOID:2531\" style=\"background-color: rgba(0,255,0,0.926470160484)\">Leukemic blasts</span> showed a heterogeneous pattern of <span title=\"23209\" style=\"background-color: rgba(0,255,0,0.926470160484)\">MLC</span> activation, ranging from 2% to 245%.</div><br /><div title=\"0.872852385044\">It was found that 13 of 13 patients with DIC, 17 of 17 patients with PE, and 10 of 12 patients with <span title=\"DOID:3393\" style=\"background-color: rgba(0,255,0,0.872852385044)\">MI</span> possessed a significantly elevated factor <span title=\"1351\" style=\"background-color: rgba(0,255,0,0.872852385044)\">VIII-related</span> antigen to factor VIII activity ratio (VIII-ratio).</div><br /><div title=\"0.883726239204\">It was found that 13 of 13 patients with DIC, 17 of 17 patients with PE, and 10 of 12 patients with <span title=\"DOID:3393\" style=\"background-color: rgba(0,255,0,0.883726239204)\">MI</span> possessed a significantly elevated factor VIII-related antigen to factor VIII activity ratio (<span title=\"1351\" style=\"background-color: rgba(0,255,0,0.883726239204)\">VIII-ratio</span>).</div><br /><div title=\"0.908989012241\">Reductions in 2 neurotransmitter synthesizing enzymes in brain, glutamic acid <span title=\"2571\" style=\"background-color: rgba(0,255,0,0.908989012241)\">decarboxylase</span> (GAD) and choline acetyltransferase (CAT), have been found in dementias of different origins, including <span title=\"DOID:10652\" style=\"background-color: rgba(0,255,0,0.908989012241)\">senile dementia</span> (Alzheimer type).</div><br /><div title=\"0.905844688416\">Reductions in 2 neurotransmitter synthesizing enzymes in brain, glutamic acid decarboxylase (<span title=\"2571\" style=\"background-color: rgba(0,255,0,0.905844688416)\">GAD)</span> and choline acetyltransferase (CAT), have been found in dementias of different origins, including <span title=\"DOID:10652\" style=\"background-color: rgba(0,255,0,0.905844688416)\">senile dementia</span> (Alzheimer type).</div><br /><div title=\"0.902546465397\">Reductions in 2 neurotransmitter synthesizing enzymes in brain, glutamic acid <span title=\"2571\" style=\"background-color: rgba(0,255,0,0.902546465397)\">decarboxylase</span> (GAD) and choline acetyltransferase (CAT), have been found in dementias of different origins, including senile dementia (<span title=\"DOID:10652\" style=\"background-color: rgba(0,255,0,0.902546465397)\">Alzheimer type)</span>.</div><br /><div title=\"0.894394934177\">Reductions in 2 neurotransmitter synthesizing enzymes in brain, glutamic acid decarboxylase (<span title=\"2571\" style=\"background-color: rgba(0,255,0,0.894394934177)\">GAD)</span> and choline acetyltransferase (CAT), have been found in dementias of different origins, including senile dementia (<span title=\"DOID:10652\" style=\"background-color: rgba(0,255,0,0.894394934177)\">Alzheimer type)</span>.</div><br /><div title=\"0.91818010807\">The 5 HT organelles/volume ratio was normal in <span title=\"178\" style=\"background-color: rgba(0,255,0,0.91818010807)\">AGL</span> and <span title=\"DOID:2531\" style=\"background-color: rgba(0,255,0,0.91818010807)\">ALL</span> but was significantly decreased in AML.</div><br /><div title=\"0.915037274361\">The 5 HT organelles/volume ratio was normal in <span title=\"178\" style=\"background-color: rgba(0,255,0,0.915037274361)\">AGL</span> and ALL but was significantly decreased in <span title=\"DOID:2531\" style=\"background-color: rgba(0,255,0,0.915037274361)\">AML</span>.</div><br /><div title=\"0.868335068226\">Cellular hypersensitivity of gp55 of RIII-murine mammary tumor virus and <span title=\"27020\" style=\"background-color: rgba(0,255,0,0.868335068226)\">gp55-like</span> protein of human <span title=\"DOID:1612\" style=\"background-color: rgba(0,255,0,0.868335068226)\">breast cancers</span>.</div><br /><div title=\"0.916970968246\">Bone marrow transplantation from an HLA identical <span title=\"23209\" style=\"background-color: rgba(0,255,0,0.916970968246)\">MLC</span> reactive sibling has been performed in a patient with <span title=\"DOID:2531\" style=\"background-color: rgba(0,255,0,0.916970968246)\">acute myelogenous leukemia</span> resistant to drug treatment.</div><br /><div title=\"0.637756705284\">Qualitative platelet parameters (volume, 5 hydroxy-tryptamine (5 HT) organelles studied by the mepacrine test, and density) were evaluated in 31 patients with acute leukaemia: 11 myelomonocytic (<span title=\"DOID:2531\" style=\"background-color: rgba(0,255,0,0.637756705284)\">AML)</span>, 8 lymphoblastic (ALL), 12 granulocytic (<span title=\"178\" style=\"background-color: rgba(0,255,0,0.637756705284)\">AGL)</span>.</div><br /><div title=\"0.896070122719\">Macrothrombocytosis was observed in most of the cases of <span title=\"DOID:2531\" style=\"background-color: rgba(0,255,0,0.896070122719)\">AML</span>, was rare in <span title=\"178\" style=\"background-color: rgba(0,255,0,0.896070122719)\">AGL</span> and was never found in ALL.</div><br /><div title=\"0.786604046822\">Macrothrombocytosis was observed in most of the cases of AML, was rare in <span title=\"178\" style=\"background-color: rgba(0,255,0,0.786604046822)\">AGL</span> and was never found in <span title=\"DOID:2531\" style=\"background-color: rgba(0,255,0,0.786604046822)\">ALL</span>.</div><br /><div title=\"0.81890308857\">The incidence of agglutinating antibodies against <span title=\"551\" style=\"background-color: rgba(0,255,0,0.81890308857)\">vasopressin</span> in <span title=\"DOID:2841\" style=\"background-color: rgba(0,255,0,0.81890308857)\">asthmatic</span> and rheumatic patients was also increased as compared with that in normal subjects and the titres were positively correlated to those against ACTH.</div><br /><div title=\"0.921119451523\">This translocation was inconsistently found in typical <span title=\"DOID:2531\" style=\"background-color: rgba(0,255,0,0.921119451523)\">APL</span> defined as M3, according to the <span title=\"2187\" style=\"background-color: rgba(0,255,0,0.921119451523)\">FAB</span> classification.</div><br /><div title=\"0.90150398016\">The prognostically favorable cell-mediated immunity appears to be directed against a component(s) which is shared by most stage 0 in situ <span title=\"DOID:1612\" style=\"background-color: rgba(0,255,0,0.90150398016)\">breast cancers</span> and the major envelope glycoprotein (<span title=\"27020\" style=\"background-color: rgba(0,255,0,0.90150398016)\">gp55)</span> of RIII murine mammary tumor virus.</div><br /><div title=\"0.915704548359\">This investigation measured in vitro cellular hypersensitivity responses of <span title=\"DOID:1612\" style=\"background-color: rgba(0,255,0,0.915704548359)\">breast cancer</span> patients to RIII mouse milk, purified <span title=\"27020\" style=\"background-color: rgba(0,255,0,0.915704548359)\">RIII-gp55</span>, C3H-MuMTV, autologous and homologous breast cancer tissues, gp50 of A-MuMTV, and preparations of Rauscher leukemia virus and Mason-Pfizer monkey virus.</div><br /><div title=\"0.903962254524\">This investigation measured in vitro cellular hypersensitivity responses of breast cancer patients to RIII mouse milk, purified <span title=\"27020\" style=\"background-color: rgba(0,255,0,0.903962254524)\">RIII-gp55</span>, C3H-MuMTV, autologous and homologous <span title=\"DOID:1612\" style=\"background-color: rgba(0,255,0,0.903962254524)\">breast cancer</span> tissues, gp50 of A-MuMTV, and preparations of Rauscher leukemia virus and Mason-Pfizer monkey virus.</div><br /><div title=\"0.573059618473\">Rates of oxidative deamination of polyamines were studied in rapidly growing hepatomas G-22 and G-27, in slowly growing <span title=\"DOID:3571\" style=\"background-color: rgba(0,255,0,0.573059618473)\">hepatomas</span> G-60, G-61, <span title=\"1774\" style=\"background-color: rgba(0,255,0,0.573059618473)\">G-48</span>, G-46 as well as in liver tissue of tumor-bearing animals and animals treated with nitrose piperidine.</div><br /><div title=\"0.906837821007\">The squamous cell tumours (n=2), anaplastic tumours (n=2) and <span title=\"DOID:1612\" style=\"background-color: rgba(0,255,0,0.906837821007)\">adenocarcinoma</span> contained insignificant <span title=\"5443\" style=\"background-color: rgba(0,255,0,0.906837821007)\">ACTH</span> levels.</div><br /><div title=\"0.905903637409\"><span title=\"4353\" style=\"background-color: rgba(0,255,0,0.905903637409)\">Myeloperoxidase</span> activity and bactericidal function of PMN in <span title=\"DOID:2355\" style=\"background-color: rgba(0,255,0,0.905903637409)\">iron deficiency</span>.</div><br /><div title=\"0.898028373718\"><span title=\"146\" style=\"background-color: rgba(0,255,0,0.898028373718)\">Alpha-1-antitrypsin</span> phenotypes were determined in 37 patients with rheumatoid arthritis and 40 patients with <span title=\"DOID:9074\" style=\"background-color: rgba(0,255,0,0.898028373718)\">systemic lupus erythematosus</span>.</div><br /><div title=\"0.793110132217\">In fact, in one case in which both <span title=\"DOID:219\" style=\"background-color: rgba(0,255,0,0.793110132217)\">colonic cancer</span> and polyps were removed, the polyps had the higher quantities of tissue <span title=\"1084\" style=\"background-color: rgba(0,255,0,0.793110132217)\">CEA</span>.</div><br /><div title=\"0.889334082603\">The structure of the <span title=\"2187\" style=\"background-color: rgba(0,255,0,0.889334082603)\">Fab</span>' fragment of a human <span title=\"DOID:2531\" style=\"background-color: rgba(0,255,0,0.889334082603)\">myeloma</span> protein (IgG1 (lambda) New) has been determined by X-ray crystallographic analysis to a nominal resolution of 0.2 nm.</div><br /><div title=\"0.894688844681\">However, a control group, which is constituted by people hospitalized in the Anti-Cancerous Center, has a <span title=\"23468\" style=\"background-color: rgba(0,255,0,0.894688844681)\">Hp 1</span> frequencie of 0,29 a well as <span title=\"DOID:1324\" style=\"background-color: rgba(0,255,0,0.894688844681)\">lung carcinoma</span>, no explication was found.</div><br /><div title=\"0.912581324577\">Plasma luteinizing hormone (LH) and follicle-stimulating hormone (FSH) levels were measured in response to <span title=\"153222\" style=\"background-color: rgba(0,255,0,0.912581324577)\">luteinizing hormone-releasing factor</span> (LRF), given as a 100 microgram intravenous bolus and/or as a 4 hour infusion of 0.2 microgram per minute to 27 normal menstruating women and 15 women with the <span title=\"DOID:11612\" style=\"background-color: rgba(0,255,0,0.912581324577)\">polycystic ovarian syndrome</span> (PCOS).</div><br /><div title=\"0.908322393894\">Plasma luteinizing hormone (LH) and follicle-stimulating hormone (FSH) levels were measured in response to luteinizing hormone-releasing factor (<span title=\"153222\" style=\"background-color: rgba(0,255,0,0.908322393894)\">LRF)</span>, given as a 100 microgram intravenous bolus and/or as a 4 hour infusion of 0.2 microgram per minute to 27 normal menstruating women and 15 women with the <span title=\"DOID:11612\" style=\"background-color: rgba(0,255,0,0.908322393894)\">polycystic ovarian syndrome</span> (PCOS).</div><br /><div title=\"0.876663506031\">Eleven out of 25 cases of <span title=\"DOID:2531\" style=\"background-color: rgba(0,255,0,0.876663506031)\">ALL</span> poorly stimulated the <span title=\"23209\" style=\"background-color: rgba(0,255,0,0.876663506031)\">MLC</span> (2% to 33% response).</div><br /><div title=\"0.906696975231\">Plasma luteinizing hormone (LH) and follicle-stimulating hormone (FSH) levels were measured in response to <span title=\"153222\" style=\"background-color: rgba(0,255,0,0.906696975231)\">luteinizing hormone-releasing factor</span> (LRF), given as a 100 microgram intravenous bolus and/or as a 4 hour infusion of 0.2 microgram per minute to 27 normal menstruating women and 15 women with the polycystic ovarian syndrome (<span title=\"DOID:11612\" style=\"background-color: rgba(0,255,0,0.906696975231)\">PCOS)</span>.</div><br /><div title=\"0.909819245338\">Plasma luteinizing hormone (LH) and follicle-stimulating hormone (FSH) levels were measured in response to luteinizing hormone-releasing factor (<span title=\"153222\" style=\"background-color: rgba(0,255,0,0.909819245338)\">LRF)</span>, given as a 100 microgram intravenous bolus and/or as a 4 hour infusion of 0.2 microgram per minute to 27 normal menstruating women and 15 women with the polycystic ovarian syndrome (<span title=\"DOID:11612\" style=\"background-color: rgba(0,255,0,0.909819245338)\">PCOS)</span>.</div><br /><div title=\"0.916473925114\">The increased pituitary LH response to <span title=\"153222\" style=\"background-color: rgba(0,255,0,0.916473925114)\">LRF</span> in <span title=\"DOID:11612\" style=\"background-color: rgba(0,255,0,0.916473925114)\">PCOS</span> is associated with a relatively large early releasable LH pool and a low FSH response.</div><br /><div title=\"0.870576262474\">In 45 patients with <span title=\"DOID:263\" style=\"background-color: rgba(0,255,0,0.870576262474)\">Wilms' tumor of the kidney</span> the IgG, IgA, and IgM serum immunoglobulin levels were quantitated and 23 antigens of HLA-A and <span title=\"3106\" style=\"background-color: rgba(0,255,0,0.870576262474)\">HLA-B</span> locues were typed on the same patients' lymphocytes.</div><br /><div title=\"0.818966567516\">The relationship between cell density and the activity of <span title=\"1267\" style=\"background-color: rgba(0,255,0,0.818966567516)\">2':3'-cyclic nucleotide 3'-phosphohydrolase</span> (CNP), an enzyme believed to be specific to oligodendroglial cells and myelin in the brain, has been studied in cultured C-6 <span title=\"DOID:3070\" style=\"background-color: rgba(0,255,0,0.818966567516)\">glioma</span> cells.</div><br /><div title=\"0.885632634163\">The relationship between cell density and the activity of 2':3'-cyclic nucleotide 3'-phosphohydrolase (<span title=\"1267\" style=\"background-color: rgba(0,255,0,0.885632634163)\">CNP)</span>, an enzyme believed to be specific to oligodendroglial cells and myelin in the brain, has been studied in cultured C-6 <span title=\"DOID:3070\" style=\"background-color: rgba(0,255,0,0.885632634163)\">glioma</span> cells.</div><br /><div title=\"0.737296938896\">It is concluded that association of lipoproteins with <span title=\"973\" style=\"background-color: rgba(0,255,0,0.737296938896)\">IgA</span> globulin in the serum of this patient with hyperlipidemia, hyper-IgA globulinemia did not prevent the development of <span title=\"DOID:1936\" style=\"background-color: rgba(0,255,0,0.737296938896)\">atherosclerotic lesions</span> and the deposition of lipids and lipoproteins in the plaques.</div><br /><div title=\"0.871480286121\">At the same time 21 of the patients with RA and 13 with <span title=\"DOID:7147\" style=\"background-color: rgba(0,255,0,0.871480286121)\">AS</span> received <span title=\"5443\" style=\"background-color: rgba(0,255,0,0.871480286121)\">ACTH</span> injections (0.25 mg twice a week).</div><br /><div title=\"0.915840685368\">As 3 of the 5 patients belonged to the RA and <span title=\"DOID:7147\" style=\"background-color: rgba(0,255,0,0.915840685368)\">AS</span> groups, the <span title=\"5443\" style=\"background-color: rgba(0,255,0,0.915840685368)\">ACTH</span> administration also has to be considered with regards to the intolerance.</div><br /><div title=\"0.904644668102\">The leucocytes obtained from severe cases of <span title=\"DOID:2355\" style=\"background-color: rgba(0,255,0,0.904644668102)\">iron-deficiency anemia</span> showed decreased <span title=\"4353\" style=\"background-color: rgba(0,255,0,0.904644668102)\">myeloperoxidase-mediated</span> iodination.</div><br /><div title=\"0.905354857445\">Defective <span title=\"4353\" style=\"background-color: rgba(0,255,0,0.905354857445)\">myeloperoxidase-mediated</span> iodination can explain the basis for the leucocyte microbicidal defect in <span title=\"DOID:2355\" style=\"background-color: rgba(0,255,0,0.905354857445)\">iron deficiency anemia</span>.</div><br /><div title=\"0.90440684557\">Three patients with SCAC of lung without distant metastases, three with SCAC of the esophagus with distant metastases but no known CNS involvement, and 17 patients with oncological conditions other than SCAC of the lung or <span title=\"DOID:10283\" style=\"background-color: rgba(0,255,0,0.90440684557)\">adenocarcinoma of the prostate</span> have failed to show elevation in serum <span title=\"1152\" style=\"background-color: rgba(0,255,0,0.90440684557)\">CK BB</span> activity.</div><br /><div title=\"0.901847183704\">Serum <span title=\"1636\" style=\"background-color: rgba(0,255,0,0.901847183704)\">angiotensin I converting enzyme</span> was found to be elevated in 56 patients with sarcoidosis (52.7 +/- 25.4 nmole per min per ml) compared to 84 normal control subjects (28.2 +/- 11.3 nmole per min per ml), 22 patients with tuberculosis (26.4 +/- 10.9 nmole per min per ml), and 20 patients with <span title=\"DOID:2531\" style=\"background-color: rgba(0,255,0,0.901847183704)\">lymphomas</span> (31.8 +/ 13.9 nmole per min per ml).</div><br /><div title=\"0.904791116714\">Studies were performed to evaluate the relative importance of enhanced adipose tissue lipolysis and increased <span title=\"3630\" style=\"background-color: rgba(0,255,0,0.904791116714)\">insulin</span> levels in modulating hepatic VLDL production in patients with <span title=\"DOID:1595\" style=\"background-color: rgba(0,255,0,0.904791116714)\">endogenous hypertriglyceridaemia</span>.</div><br /><div title=\"0.917662203312\">The peak release of LH in response to 56 microgram <span title=\"153222\" style=\"background-color: rgba(0,255,0,0.917662203312)\">LRF</span> in ovulatory <span title=\"DOID:11612\" style=\"background-color: rgba(0,255,0,0.917662203312)\">PCO</span> was similar in controls but LH responses in anovulatory PCO were significantly greater.</div><br /><div title=\"0.913694679737\">The peak release of LH in response to 56 microgram <span title=\"153222\" style=\"background-color: rgba(0,255,0,0.913694679737)\">LRF</span> in ovulatory PCO was similar in controls but LH responses in <span title=\"DOID:11612\" style=\"background-color: rgba(0,255,0,0.913694679737)\">anovulatory PCO</span> were significantly greater.</div><br /><div title=\"0.632652819157\">Role of <span title=\"3630\" style=\"background-color: rgba(0,255,0,0.632652819157)\">insulin</span> resistance in adipose tissue and liver in the pathogenesis of <span title=\"DOID:1595\" style=\"background-color: rgba(0,255,0,0.632652819157)\">endogenous hypertriglyceridaemia</span> in man.</div><br /><div title=\"0.886957705021\">The critical role of a <span title=\"27020\" style=\"background-color: rgba(0,255,0,0.886957705021)\">gp55-like</span> protein as the antigen responded to by <span title=\"DOID:1612\" style=\"background-color: rgba(0,255,0,0.886957705021)\">breast cancer</span> patients' in leukocytes was also suggested by the ability of anti-gp55 antiserum to decrease leukocyte responsiveness to RIII-gp55, C3H-MuMTV, and breast cancer tissues.</div><br /><div title=\"0.757515192032\">HLA and <span title=\"23209\" style=\"background-color: rgba(0,255,0,0.757515192032)\">MLC</span> typing in patients with <span title=\"DOID:2531\" style=\"background-color: rgba(0,255,0,0.757515192032)\">Hodgkin's disease</span>.</div><br /><div title=\"0.907857716084\">The critical role of a gp55-like protein as the antigen responded to by <span title=\"DOID:1612\" style=\"background-color: rgba(0,255,0,0.907857716084)\">breast cancer</span> patients' in leukocytes was also suggested by the ability of <span title=\"27020\" style=\"background-color: rgba(0,255,0,0.907857716084)\">anti-gp55</span> antiserum to decrease leukocyte responsiveness to RIII-gp55, C3H-MuMTV, and breast cancer tissues.</div><br /><div title=\"0.915093302727\">The critical role of a gp55-like protein as the antigen responded to by <span title=\"DOID:1612\" style=\"background-color: rgba(0,255,0,0.915093302727)\">breast cancer</span> patients' in leukocytes was also suggested by the ability of anti-gp55 antiserum to decrease leukocyte responsiveness to <span title=\"27020\" style=\"background-color: rgba(0,255,0,0.915093302727)\">RIII-gp55</span>, C3H-MuMTV, and breast cancer tissues.</div><br /><div title=\"0.89346331358\">The critical role of a <span title=\"27020\" style=\"background-color: rgba(0,255,0,0.89346331358)\">gp55-like</span> protein as the antigen responded to by breast cancer patients' in leukocytes was also suggested by the ability of anti-gp55 antiserum to decrease leukocyte responsiveness to RIII-gp55, C3H-MuMTV, and <span title=\"DOID:1612\" style=\"background-color: rgba(0,255,0,0.89346331358)\">breast cancer</span> tissues.</div><br /><div title=\"0.914862930775\">The critical role of a gp55-like protein as the antigen responded to by breast cancer patients' in leukocytes was also suggested by the ability of <span title=\"27020\" style=\"background-color: rgba(0,255,0,0.914862930775)\">anti-gp55</span> antiserum to decrease leukocyte responsiveness to RIII-gp55, C3H-MuMTV, and <span title=\"DOID:1612\" style=\"background-color: rgba(0,255,0,0.914862930775)\">breast cancer</span> tissues.</div><br /><div title=\"0.917930006981\">The critical role of a gp55-like protein as the antigen responded to by breast cancer patients' in leukocytes was also suggested by the ability of anti-gp55 antiserum to decrease leukocyte responsiveness to <span title=\"27020\" style=\"background-color: rgba(0,255,0,0.917930006981)\">RIII-gp55</span>, C3H-MuMTV, and <span title=\"DOID:1612\" style=\"background-color: rgba(0,255,0,0.917930006981)\">breast cancer</span> tissues.</div><br /><div title=\"0.886538743973\">Factors of the plasma <span title=\"9622\" style=\"background-color: rgba(0,255,0,0.886538743973)\">kallikrein</span> system have been evaluated following the course of 48 patients with <span title=\"DOID:2531\" style=\"background-color: rgba(0,255,0,0.886538743973)\">hematological malignancies</span> which consisted of 15 cases of AML, 6 cases of myeloproliferative disorders, 14 of lymphoproliferative disorders, 8 of multiple myeloma and 5 of bone marrow carcinomatoses.</div><br /><div title=\"0.893439233303\">Factors of the plasma <span title=\"9622\" style=\"background-color: rgba(0,255,0,0.893439233303)\">kallikrein</span> system have been evaluated following the course of 48 patients with hematological malignancies which consisted of 15 cases of <span title=\"DOID:2531\" style=\"background-color: rgba(0,255,0,0.893439233303)\">AML</span>, 6 cases of myeloproliferative disorders, 14 of lymphoproliferative disorders, 8 of multiple myeloma and 5 of bone marrow carcinomatoses.</div><br /><div title=\"0.899692237377\">Factors of the plasma <span title=\"9622\" style=\"background-color: rgba(0,255,0,0.899692237377)\">kallikrein</span> system have been evaluated following the course of 48 patients with hematological malignancies which consisted of 15 cases of AML, 6 cases of <span title=\"DOID:2531\" style=\"background-color: rgba(0,255,0,0.899692237377)\">myeloproliferative disorders</span>, 14 of lymphoproliferative disorders, 8 of multiple myeloma and 5 of bone marrow carcinomatoses.</div><br /><div title=\"0.876843750477\">Factors of the plasma <span title=\"9622\" style=\"background-color: rgba(0,255,0,0.876843750477)\">kallikrein</span> system have been evaluated following the course of 48 patients with hematological malignancies which consisted of 15 cases of AML, 6 cases of myeloproliferative disorders, 14 of lymphoproliferative disorders, 8 of multiple <span title=\"DOID:2531\" style=\"background-color: rgba(0,255,0,0.876843750477)\">myeloma</span> and 5 of bone marrow carcinomatoses.</div><br /><div title=\"0.915750682354\">An assay of serum <span title=\"1636\" style=\"background-color: rgba(0,255,0,0.915750682354)\">ACE</span> is a useful tool for regulating therapy in sarcoidosis and for confirming the diagnosis, since it readily distinguishes these patients from others with tuberculosis, lung cancer or <span title=\"DOID:2531\" style=\"background-color: rgba(0,255,0,0.915750682354)\">lymphoma</span>.</div><br /><div title=\"0.904126226902\">The results thus indicate that the rate of FFA release to plasma constitutes the predominant factor in determining hepatic output of VLDL and that in the majority of patients with <span title=\"DOID:1595\" style=\"background-color: rgba(0,255,0,0.904126226902)\">endogenous hypertriglyceridaemia</span> the increased FFA flux resulting from <span title=\"3630\" style=\"background-color: rgba(0,255,0,0.904126226902)\">insulin</span> resistance in adipose tissue could effectively increase VLDL production.</div><br /><div title=\"0.906442821026\">Pituitary response to bolus and continuous intravenous infusion of <span title=\"153222\" style=\"background-color: rgba(0,255,0,0.906442821026)\">luteinizing hormone-releasing factor</span> in normal women and women with <span title=\"DOID:11612\" style=\"background-color: rgba(0,255,0,0.906442821026)\">polycystic ovarian syndrome</span>.</div><br /><div title=\"0.910502791405\">Production of hydrogenperoxide and <span title=\"4353\" style=\"background-color: rgba(0,255,0,0.910502791405)\">myeloperoxidase-mediated</span> iodination, by leucocytes was studied in normal subjects and subjects suffering from <span title=\"DOID:2355\" style=\"background-color: rgba(0,255,0,0.910502791405)\">iron-deficiency anemia</span>.</div><br /><div title=\"0.913538634777\">Immunologic markers strongly supported a B-lymphoid origin in this case, while cytogenetic analysis indicated a large number of consistent chromosomal rearrangements, including a translocation involving chromosomes <span title=\"4843\" style=\"background-color: rgba(0,255,0,0.913538634777)\">Nos.</span> 8 and 14 which has been previously reported to occur primarily in <span title=\"DOID:2531\" style=\"background-color: rgba(0,255,0,0.913538634777)\">Burkitt's lymphoma</span>.</div><br /><div title=\"0.820904493332\">An antiserum raised against myelomonocytic and monocytic <span title=\"DOID:2531\" style=\"background-color: rgba(0,255,0,0.820904493332)\">leukaemia</span> cells has been used to define a <span title=\"963\" style=\"background-color: rgba(0,255,0,0.820904493332)\">cell surface antigen</span> shared by normal and leukaemic cells of the granulocyte and monocyte cell lines.</div><br /><div title=\"0.676444709301\">Hepatic <span title=\"3630\" style=\"background-color: rgba(0,255,0,0.676444709301)\">insulin</span> responsiveness in patients with <span title=\"DOID:1595\" style=\"background-color: rgba(0,255,0,0.676444709301)\">endogenous hypertriglyceridaemia</span>.</div><br /><div title=\"0.892712891102\"><span title=\"4000\" style=\"background-color: rgba(0,255,0,0.892712891102)\">Intraductal carcinoma (IDC)</span> was identified more often at frozen section (45%) than was <span title=\"DOID:1612\" style=\"background-color: rgba(0,255,0,0.892712891102)\">lobular carcinoma</span> in situ (19%).</div><br /><div title=\"0.908482611179\"><span title=\"146\" style=\"background-color: rgba(0,255,0,0.908482611179)\">Alpha-1-antitrypsin</span> phenotypes in rheumatoid arthritis and <span title=\"DOID:9074\" style=\"background-color: rgba(0,255,0,0.908482611179)\">systemic lupus erythematosus</span>.</div><br /><div title=\"0.776548683643\">Thus results have been shown only for diazepam and chlordiazepoxid, which indicate an effect of the plasma protein binding on distribution and pharmacological activity, for example the existence of a direct correlation between unwanted CNS <span title=\"DOID:1595\" style=\"background-color: rgba(0,255,0,0.776548683643)\">depressions</span> and low plasma <span title=\"213\" style=\"background-color: rgba(0,255,0,0.776548683643)\">albumin</span> concentrations and a direct correlation between the plasma protein binding and the biological half-life.</div><br /><div title=\"0.908383846283\">Cholesterol (P less than 0.05), positivity of Lp (a)/<span title=\"3779\" style=\"background-color: rgba(0,255,0,0.908383846283)\">pre-beta1</span> lipoprotein (P less than 0.01), a family history of <span title=\"DOID:3393\" style=\"background-color: rgba(0,255,0,0.908383846283)\">coronary heart disease</span> (P less than 0.05), and smoking (P less than 0.01) differed between the group of normal arteries and the whole group of luminal obstructions.</div><br /><div title=\"0.91017383337\">In <span title=\"DOID:10763\" style=\"background-color: rgba(0,255,0,0.91017383337)\">pre-eclampsia</span> resulting in a small full term baby, <span title=\"9354\" style=\"background-color: rgba(0,255,0,0.91017383337)\">E4</span> levels were mostly below normal mean values or failed to show an increased pattern.</div><br /><div title=\"0.656922459602\">The significance of the <span title=\"23209\" style=\"background-color: rgba(0,255,0,0.656922459602)\">MLC-activating</span> properties of <span title=\"DOID:2531\" style=\"background-color: rgba(0,255,0,0.656922459602)\">leukemic blasts</span> for the classification and immunotherapeutic use of ALL is discussed.</div><br /><div title=\"0.8741517663\">Correlation of the <span title=\"2187\" style=\"background-color: rgba(0,255,0,0.8741517663)\">FAB</span> morphologic criteria and prognosis in <span title=\"DOID:2531\" style=\"background-color: rgba(0,255,0,0.8741517663)\">acute lymphocytic leukemia</span> of childhood.</div><br /><div title=\"0.653325378895\"><span title=\"5443\" style=\"background-color: rgba(0,255,0,0.653325378895)\">ACTH</span> was detectable (greater than 1 ng ACTH equivalent/g wet weight) tissue in 47 of 49 specimens of epidermoid carcinoma, in 15 of 17 specimens of <span title=\"DOID:1612\" style=\"background-color: rgba(0,255,0,0.653325378895)\">adenocarcinoma</span> and in 7 of 8 specimens of large cell carcinoma; the median concentrations in these three tumor types were 8, 3 and 9 ng/g, respectively.</div><br /><div title=\"0.922931969166\">Malignant tumor cells were detected in 266 specimens obtained from 106 children with the following malignant neoplasms: leukemia 44/133, malignant lymphoma 13/64, soft tissue sarcoma 13/48, neuroblastoma 13/26, <span title=\"DOID:263\" style=\"background-color: rgba(0,255,0,0.922931969166)\">Wilms' tumor</span> 4/18, malignant teratoma 4/13, osteogenic sarcoma 7/11, Ewing's sarcoma 2/10, brain tumor 5/6 and retinoblastoma <span title=\"5925\" style=\"background-color: rgba(0,255,0,0.922931969166)\">1/1</span>.</div><br /><div title=\"0.913547039032\">Significant concentrations of immunocative (greater than 3 ng/g wet weight) and bioactive (greater than 0.2 ng/g wet weight) <span title=\"5443\" style=\"background-color: rgba(0,255,0,0.913547039032)\">ACTH</span> were found in all the carcinoid and oat cell tumours (n=9), a combined tumour (poorly differentiated <span title=\"DOID:1612\" style=\"background-color: rgba(0,255,0,0.913547039032)\">adenocarcinoma</span> with large cell carcinoid elements), and a poorly differentiated squamous cell tumour.</div><br /><div title=\"0.839996397495\">A bone marrow transplantation from an HLA-identical, <span title=\"23209\" style=\"background-color: rgba(0,255,0,0.839996397495)\">MLC</span> nonreactive paternal donor has been performed in a patient with <span title=\"DOID:2531\" style=\"background-color: rgba(0,255,0,0.839996397495)\">acute lymphoblastic leukemia</span> resistant to drug treatment.</div><br /><div title=\"0.905179679394\">Marrow transplantation in aplastic anemia and <span title=\"DOID:2531\" style=\"background-color: rgba(0,255,0,0.905179679394)\">leukemia</span> has generally been limited to siblings who have been histocompatible at both the serological (A and B) and lymphocyte determined (D or <span title=\"23209\" style=\"background-color: rgba(0,255,0,0.905179679394)\">MLC)</span> loci of the HLA system.</div><br /><div title=\"0.906464397907\">Cholesterol, positivity of the Lp(a)/<span title=\"3779\" style=\"background-color: rgba(0,255,0,0.906464397907)\">pre-beta1</span> lipoprotein and a family history of <span title=\"DOID:3393\" style=\"background-color: rgba(0,255,0,0.906464397907)\">coronary heart disease</span> were also associated with the severity of the disease.</div><br /><div title=\"0.532797634602\">The observations indicate a role for <span title=\"1152\" style=\"background-color: rgba(0,255,0,0.532797634602)\">CK-BB</span> as a tumor marker, particularly for <span title=\"DOID:10283\" style=\"background-color: rgba(0,255,0,0.532797634602)\">adenocarcinoma of the prostate</span>.</div><br /><div title=\"0.857388436794\">On the basis of reports in the literature and of our own clinical experience it appears that <span title=\"4282\" style=\"background-color: rgba(0,255,0,0.857388436794)\">melanocyte inhibiting factor</span> (MIF) is a very promising therapeutic agent in the management of <span title=\"DOID:14330\" style=\"background-color: rgba(0,255,0,0.857388436794)\">Parkinson's disease</span>.</div><br /><div title=\"0.923448503017\"><span title=\"DOID:0050741\" style=\"background-color: rgba(0,255,0,0.923448503017)\">Chronic</span> alcohol intoxication at a certain stage is connected with a considerable reduction in the ratio of alcohol <span title=\"10327\" style=\"background-color: rgba(0,255,0,0.923448503017)\">dehydrogenase</span>:acetaldehyde dehydrogenase (this ratio determines the severity of clinical signs in intoxication).</div><br /><div title=\"0.92879229784\">Chronic alcohol <span title=\"DOID:0050741\" style=\"background-color: rgba(0,255,0,0.92879229784)\">intoxication</span> at a certain stage is connected with a considerable reduction in the ratio of alcohol <span title=\"10327\" style=\"background-color: rgba(0,255,0,0.92879229784)\">dehydrogenase</span>:acetaldehyde dehydrogenase (this ratio determines the severity of clinical signs in intoxication).</div><br /><div title=\"0.894935131073\">A <span title=\"1152\" style=\"background-color: rgba(0,255,0,0.894935131073)\">CK(BB)</span> fraction was observed in sera of a patient with <span title=\"DOID:10283\" style=\"background-color: rgba(0,255,0,0.894935131073)\">prostatic carcinoma</span>.</div><br /><div title=\"0.913767457008\">This discrepancy might be caused by differences between the individual HL-A antigens involved in the afferent phase (<span title=\"23209\" style=\"background-color: rgba(0,255,0,0.913767457008)\">MLC)</span> and/or the efferent phase (<span title=\"DOID:2531\" style=\"background-color: rgba(0,255,0,0.913767457008)\">CML)</span>.</div><br /><div title=\"0.903708398342\">Letter: <span title=\"2688\" style=\"background-color: rgba(0,255,0,0.903708398342)\">Growth-hormone</span> responses in <span title=\"DOID:14330\" style=\"background-color: rgba(0,255,0,0.903708398342)\">Parkinson's disease</span>.</div><br /><div title=\"0.913200139999\">Stimulation of the vagus nerve as well as infusion of <span title=\"6343\" style=\"background-color: rgba(0,255,0,0.913200139999)\">secretin</span> and/or CCK evoked a pronounced secretion and a small to moderate <span title=\"DOID:10763\" style=\"background-color: rgba(0,255,0,0.913200139999)\">increase in pancreatic blood flow</span>, but did not significantly change the plasma osmolality in the venous effluent from the gland.</div><br /><div title=\"0.911867439747\">Similar <span title=\"171425\" style=\"background-color: rgba(0,255,0,0.911867439747)\">ClB</span> based on IBW in normal and <span title=\"DOID:9970\" style=\"background-color: rgba(0,255,0,0.911867439747)\">obese</span> subjects indicates that IBW should be used to calculate maintenance doses for theophylline.</div><br /><div title=\"0.910369575024\">The <span title=\"171425\" style=\"background-color: rgba(0,255,0,0.910369575024)\">ClB</span> averaged 63.0 (28.5) ml/hr/kg IBW in normals compared to 32.8 (11.1) ml/hr/kg TBW and 64.1 (20.8) ml/hr/kg IBW in <span title=\"DOID:9970\" style=\"background-color: rgba(0,255,0,0.910369575024)\">obese</span> subjects.</div><br /><div title=\"0.917606711388\">Blood glucose, lipoproteins, non-esterified fatty acids, <span title=\"2244\" style=\"background-color: rgba(0,255,0,0.917606711388)\">fibrinogen</span> and intermediary metabolites were measured in twenty-two diet failed <span title=\"DOID:9352\" style=\"background-color: rgba(0,255,0,0.917606711388)\">maturity</span> onset diabetics during a double blind crossover study of metformin (1.7 g/day) or clofibrate (2 g/day) therapy.</div><br /><div title=\"0.908877372742\">Relationship between estrogen receptors, <span title=\"51478\" style=\"background-color: rgba(0,255,0,0.908877372742)\">17 beta-hydroxysteroid dehydrogenase</span> and estrogen content in human <span title=\"DOID:1612\" style=\"background-color: rgba(0,255,0,0.908877372742)\">breast cancer</span>.</div><br /><div title=\"0.607894778252\">During initial evaluation, 5 patients had blunted <span title=\"2688\" style=\"background-color: rgba(0,255,0,0.607894778252)\">GH</span> response to <span title=\"DOID:9744\" style=\"background-color: rgba(0,255,0,0.607894778252)\">IIH</span>, 12 responded subnormally to AI and 4 failed to respond normally to either stimulus.</div><br /><div title=\"0.892142593861\">A significant increase in the level of serine <span title=\"2147\" style=\"background-color: rgba(0,255,0,0.892142593861)\">protease</span> was found in muscle of patients with Duchenne-type muscular dystrophy and with Becker-type muscular dystrophy, but the activity was not increased in muscle of a patient with <span title=\"DOID:332\" style=\"background-color: rgba(0,255,0,0.892142593861)\">amyotrophic lateral sclerosis</span>.</div><br /><div title=\"0.804404377937\">Seventeen patients with metastatic <span title=\"DOID:263\" style=\"background-color: rgba(0,255,0,0.804404377937)\">renal cell carcinoma</span> were treated with <span title=\"10309\" style=\"background-color: rgba(0,255,0,0.804404377937)\">CCNU</span>, vinblastine and Delalutin.</div><br /><div title=\"0.554036438465\">The significance of creatine kinase (<span title=\"1152\" style=\"background-color: rgba(0,255,0,0.554036438465)\">CKBB)</span> in metastatic <span title=\"DOID:10283\" style=\"background-color: rgba(0,255,0,0.554036438465)\">cancer of the prostate</span>.</div><br /><div title=\"0.891923189163\">Estrone and estradiol levels in tumor tissue cytosols were determined in 11 premenopausal and 20 postmenopausal women at the same time that <span title=\"51478\" style=\"background-color: rgba(0,255,0,0.891923189163)\">17 beta-hydroxysteroid dehydrogenase</span> and estrogen receptors (ER) were carried out on their <span title=\"DOID:1612\" style=\"background-color: rgba(0,255,0,0.891923189163)\">breast cancers</span>.</div><br /><div title=\"0.894736945629\">A metastatic tumor of a <span title=\"DOID:10283\" style=\"background-color: rgba(0,255,0,0.894736945629)\">prostatic carcinoma</span> was observed to contain solely the <span title=\"1152\" style=\"background-color: rgba(0,255,0,0.894736945629)\">CK(BB)</span> isozyme.</div><br /><div title=\"0.688601016998\">[Correlation between ectopic production of beta1-glycoprotein and human <span title=\"1443\" style=\"background-color: rgba(0,255,0,0.688601016998)\">placental lactogen</span> and prognosis of <span title=\"DOID:1612\" style=\"background-color: rgba(0,255,0,0.688601016998)\">breast cancer]</span>.</div><br /><div title=\"0.877239882946\">[Infusion therapy with mif (<span title=\"4282\" style=\"background-color: rgba(0,255,0,0.877239882946)\">melanocyte inhibiting factor)</span> in <span title=\"DOID:14330\" style=\"background-color: rgba(0,255,0,0.877239882946)\">Parkinson's disease</span> (author's transl)].</div><br /><div title=\"0.815500438213\">Distribution of childhood <span title=\"DOID:2531\" style=\"background-color: rgba(0,255,0,0.815500438213)\">leukaemia</span> according to the <span title=\"2187\" style=\"background-color: rgba(0,255,0,0.815500438213)\">FAB-classification</span>.</div><br /><div title=\"0.881105422974\">Serum <span title=\"2224\" style=\"background-color: rgba(0,255,0,0.881105422974)\">FDPs</span> were investigated in 30 healthy and 95 patients with pulmonary thrombembolia, not-stabilized angina pectoris, <span title=\"DOID:3393\" style=\"background-color: rgba(0,255,0,0.881105422974)\">myocardial infarction</span>, rheumatism, rheumatoid arthritis, lupus erythematodes and dermatomyositis.</div><br /><div title=\"0.908728599548\">Growth hormone (GH) and <span title=\"5617\" style=\"background-color: rgba(0,255,0,0.908728599548)\">prolactin</span> (PR) secretion were evaluated in 28 patients who had sleep apnea or <span title=\"DOID:8986\" style=\"background-color: rgba(0,255,0,0.908728599548)\">narcolepsy</span> but no other primary neurologic or endocrine disorders.</div><br /><div title=\"0.853481173515\">The net increase in FSH was significantly greater (P less than 0.001) in the <span title=\"DOID:11612\" style=\"background-color: rgba(0,255,0,0.853481173515)\">PCO</span> patients than the normal women with maximal doses of <span title=\"153222\" style=\"background-color: rgba(0,255,0,0.853481173515)\">LRF</span>.</div><br /><div title=\"0.715022623539\">The occurrence of the <span title=\"10162\" style=\"background-color: rgba(0,255,0,0.715022623539)\">C3F</span> allele was investigated in the following three groups: 69 consecutive referred patients with untreated essential <span title=\"DOID:10763\" style=\"background-color: rgba(0,255,0,0.715022623539)\">hypertension</span>, including borderline hypertension; 70 patients with established and treated essential hypertension, already attending the same outpatient clinic, and 62 age- and sex-matched normotensive healthy subjects without clinical signs of atherosclerosis or familial predisposition to hypertension.</div><br /><div title=\"0.823368191719\">The occurrence of the <span title=\"10162\" style=\"background-color: rgba(0,255,0,0.823368191719)\">C3F</span> allele was investigated in the following three groups: 69 consecutive referred patients with untreated essential hypertension, including borderline <span title=\"DOID:10763\" style=\"background-color: rgba(0,255,0,0.823368191719)\">hypertension</span>; 70 patients with established and treated essential hypertension, already attending the same outpatient clinic, and 62 age- and sex-matched normotensive healthy subjects without clinical signs of atherosclerosis or familial predisposition to hypertension.</div><br /><div title=\"0.778591454029\">The occurrence of the <span title=\"10162\" style=\"background-color: rgba(0,255,0,0.778591454029)\">C3F</span> allele was investigated in the following three groups: 69 consecutive referred patients with untreated essential hypertension, including borderline hypertension; 70 patients with established and treated essential <span title=\"DOID:10763\" style=\"background-color: rgba(0,255,0,0.778591454029)\">hypertension</span>, already attending the same outpatient clinic, and 62 age- and sex-matched normotensive healthy subjects without clinical signs of atherosclerosis or familial predisposition to hypertension.</div><br /><div title=\"0.848605751991\">The occurrence of the <span title=\"10162\" style=\"background-color: rgba(0,255,0,0.848605751991)\">C3F</span> allele was investigated in the following three groups: 69 consecutive referred patients with untreated essential hypertension, including borderline hypertension; 70 patients with established and treated essential hypertension, already attending the same outpatient clinic, and 62 age- and sex-matched normotensive healthy subjects without clinical signs of atherosclerosis or familial predisposition to <span title=\"DOID:10763\" style=\"background-color: rgba(0,255,0,0.848605751991)\">hypertension</span>.</div><br /><div title=\"0.899091482162\">Serum <span title=\"973\" style=\"background-color: rgba(0,255,0,0.899091482162)\">immunoglobulin A</span> (IgA) levels in <span title=\"DOID:11934\" style=\"background-color: rgba(0,255,0,0.899091482162)\">carcinoma of the head and neck</span>.</div><br /><div title=\"0.777699351311\">Serum immunoglobulin A (<span title=\"973\" style=\"background-color: rgba(0,255,0,0.777699351311)\">IgA)</span> levels in <span title=\"DOID:11934\" style=\"background-color: rgba(0,255,0,0.777699351311)\">carcinoma of the head and neck</span>.</div><br /><div title=\"0.912827074528\">Finally, because of its lack of specificity, the practical importance of <span title=\"2821\" style=\"background-color: rgba(0,255,0,0.912827074528)\">PHI</span> measurement in the clinical diagnosis of <span title=\"DOID:3393\" style=\"background-color: rgba(0,255,0,0.912827074528)\">myocardial infarction</span> is small.</div><br /><div title=\"0.891010284424\">Effects of insulin, human <span title=\"1443\" style=\"background-color: rgba(0,255,0,0.891010284424)\">placental lactogen</span> and human growth hormone of DNA synthesis in organ cultures of benign human <span title=\"DOID:1612\" style=\"background-color: rgba(0,255,0,0.891010284424)\">breast tumours</span>.</div><br /><div title=\"0.51092594862\">Chemotherapy of <span title=\"DOID:3070\" style=\"background-color: rgba(0,255,0,0.51092594862)\">malignant gliomas</span>: comparison of the effect of polychemo- and <span title=\"10309\" style=\"background-color: rgba(0,255,0,0.51092594862)\">CCNU-therapy</span>.</div><br /><div title=\"0.889681279659\">Stimulation of DNA synthesis by human <span title=\"1443\" style=\"background-color: rgba(0,255,0,0.889681279659)\">placental lactogen</span> or insulin in organ cultures of benign human <span title=\"DOID:1612\" style=\"background-color: rgba(0,255,0,0.889681279659)\">breast tumors</span>.</div><br /><div title=\"0.912790358067\">Weak, but definite <span title=\"DOID:263\" style=\"background-color: rgba(0,255,0,0.912790358067)\">CML</span> activity was generated during MLC with cells differing at HLA-A and <span title=\"3106\" style=\"background-color: rgba(0,255,0,0.912790358067)\">HLA-B</span> but sharing HLA-D.</div><br /><div title=\"0.912799298763\">Nigerian children with <span title=\"DOID:1826\" style=\"background-color: rgba(0,255,0,0.912799298763)\">convulsions</span> and Plasmodium falciparium parasitaemia above 100,000/microliter did not show a decreased frequency of <span title=\"2539\" style=\"background-color: rgba(0,255,0,0.912799298763)\">glucose-6-phosphate-dehydrogenase</span> (G.-6-P.D.) deficiency.</div><br /><div title=\"0.725135982037\">These observations indicate that the measurement of complements C3 and C4, and <span title=\"7018\" style=\"background-color: rgba(0,255,0,0.725135982037)\">transferrin</span> in the prostatic fluid may assist in the identification of patients with a high risk of <span title=\"DOID:10283\" style=\"background-color: rgba(0,255,0,0.725135982037)\">prostatic cancer</span>.</div><br /><div title=\"0.912124454975\">Earlier studies on antisera against <span title=\"2187\" style=\"background-color: rgba(0,255,0,0.912124454975)\">Fab</span> of pooled human IgG and <span title=\"DOID:2531\" style=\"background-color: rgba(0,255,0,0.912124454975)\">IgA myeloma</span> proteins disclosed the presence of class-specific Fd antibodies, the demonstration of which required interaction of heavy and light chains.</div><br /><div title=\"0.872163653374\">417 of 455 uncomplicated cases (91.6%) of <span title=\"DOID:2355\" style=\"background-color: rgba(0,255,0,0.872163653374)\">iron deficiency</span>, heterozygous <span title=\"146\" style=\"background-color: rgba(0,255,0,0.872163653374)\">alpha1- and beta</span>- thalassaemia were correctly identified.</div><br /><div title=\"0.614893078804\">In 100 children with <span title=\"DOID:2531\" style=\"background-color: rgba(0,255,0,0.614893078804)\">acute lymphatic leukaemia</span> the cytomorphological subclassification of the pathological cell type was made according to Math   and the French-American-British Co-operative group (<span title=\"2187\" style=\"background-color: rgba(0,255,0,0.614893078804)\">FAB)</span>.</div><br /><div title=\"0.902317166328\">In comparison to serum from healthy persons, there was elevated <span title=\"3426\" style=\"background-color: rgba(0,255,0,0.902317166328)\">CFI</span> in the serum from patients with sarcoidosis and <span title=\"DOID:2531\" style=\"background-color: rgba(0,255,0,0.902317166328)\">Hodgkin's disease</span> by both assay systems.</div><br /><div title=\"0.888279974461\">The magnitude of the <span title=\"4023\" style=\"background-color: rgba(0,255,0,0.888279974461)\">LPL</span> response was different in normals and in patients with <span title=\"DOID:1595\" style=\"background-color: rgba(0,255,0,0.888279974461)\">endogenous hyperlipoproteinemia</span>.</div><br /><div title=\"0.88602668047\">The specific activities of <span title=\"1719\" style=\"background-color: rgba(0,255,0,0.88602668047)\">DHFR</span> in primary human <span title=\"DOID:1319\" style=\"background-color: rgba(0,255,0,0.88602668047)\">brain tumor</span> tissues were comparable to those found in avian sarcoma virus-induced brain tumors in rats.</div><br /><div title=\"0.572628498077\">The specific activities of <span title=\"1719\" style=\"background-color: rgba(0,255,0,0.572628498077)\">DHFR</span> in primary human brain tumor tissues were comparable to those found in avian sarcoma virus-induced <span title=\"DOID:1319\" style=\"background-color: rgba(0,255,0,0.572628498077)\">brain tumors</span> in rats.</div><br /><div title=\"0.928135752678\"><span title=\"DOID:2531\" style=\"background-color: rgba(0,255,0,0.928135752678)\">Moloney lymphoma</span> cells express a polyprotein containing the GAG gene-coded p15 and the Moloney leukemia virus-induced <span title=\"963\" style=\"background-color: rgba(0,255,0,0.928135752678)\">cell surface antigen</span> (MCSA).</div><br /><div title=\"0.917368471622\">Moloney lymphoma cells express a polyprotein containing the GAG gene-coded p15 and the <span title=\"DOID:2531\" style=\"background-color: rgba(0,255,0,0.917368471622)\">Moloney leukemia</span> virus-induced <span title=\"963\" style=\"background-color: rgba(0,255,0,0.917368471622)\">cell surface antigen</span> (MCSA).</div><br /><div title=\"0.905772209167\">6 cases of non-A <span title=\"DOID:2043\" style=\"background-color: rgba(0,255,0,0.905772209167)\">non-B hepatitis</span> which followed administration of four different batches of concentrates of <span title=\"2158\" style=\"background-color: rgba(0,255,0,0.905772209167)\">coagulation factor IX</span> from commercial and non-commercial sources are described.</div><br /><div title=\"0.856329917908\">Effector cells for cell-mediated lysis (<span title=\"DOID:263\" style=\"background-color: rgba(0,255,0,0.856329917908)\">CML)</span> were generated by in vitro culture of lymphocytes from selected donors with X-irradiated cells from unrelated subjects who were HLA-D homozygous and matched to the responders for the antigens of the HLA-A and <span title=\"3106\" style=\"background-color: rgba(0,255,0,0.856329917908)\">HLA-B</span> regions.</div><br /><div title=\"0.806929886341\">In addition to cellular retinol-binding protein (CRBP) and retinoic acid-binding protein (<span title=\"1381\" style=\"background-color: rgba(0,255,0,0.806929886341)\">CRABP)</span>, a new molecular species having affinity for both retinol and retinoic acid was detected in the cytosols obtained from hepatocellular carcinoma as well as <span title=\"DOID:3070\" style=\"background-color: rgba(0,255,0,0.806929886341)\">glioma</span> by means of gel filtration on Sephadex G-75.</div><br /><div title=\"0.904982507229\">An antiserum to the Fabalpha fragment of human IgA was prepared by injecting K-and lambda-type IgA1 <span title=\"DOID:2531\" style=\"background-color: rgba(0,255,0,0.904982507229)\">myeloma</span> protein <span title=\"2187\" style=\"background-color: rgba(0,255,0,0.904982507229)\">Fab</span> fragments in complete Freund's adjuvant into a goat.</div><br /><div title=\"0.725283265114\"><span title=\"1791\" style=\"background-color: rgba(0,255,0,0.725283265114)\">Terminal deoxynucleotidyl transferase</span> in <span title=\"DOID:2355\" style=\"background-color: rgba(0,255,0,0.725283265114)\">Fanconi's anaemia</span>.</div><br /><div title=\"0.86063760519\">In A204 human <span title=\"DOID:4045\" style=\"background-color: rgba(0,255,0,0.86063760519)\">rhabdomyosarcoma</span> cells, a protein of 73,000 daltons (<span title=\"51280\" style=\"background-color: rgba(0,255,0,0.86063760519)\">gp73)</span> represented the major viral glycoprotein as determined by [3H]glucosamine labeling.</div><br /><div title=\"0.89169895649\">These results provide evidence that insulin and human <span title=\"1443\" style=\"background-color: rgba(0,255,0,0.89169895649)\">placental lactogen</span>, but not human growth hormone, may be important factors in the aetiology of benign human <span title=\"DOID:1612\" style=\"background-color: rgba(0,255,0,0.89169895649)\">breast tumours</span>.</div><br /><div title=\"0.88230484724\">Measurements of <span title=\"6948\" style=\"background-color: rgba(0,255,0,0.88230484724)\">transcobalamin II</span> (T.C. II) concentrations in 26 patients with <span title=\"DOID:9074\" style=\"background-color: rgba(0,255,0,0.88230484724)\">lupus erythematosus</span>, 4 with dermatomyositis, 2 with autoimmune haemolytic anaemia, and in 40 immunosuppressed renal-transplant patients showed that T.C. II levels were raised during active phases of autoimmune disease.</div><br /><div title=\"0.88462549448\">Serum <span title=\"973\" style=\"background-color: rgba(0,255,0,0.88462549448)\">immunoglobulin A</span> (IgA), immunoglobulin G (IgG), and immunoglobulin M (IgM) levels were determined on 245 patients with <span title=\"DOID:11934\" style=\"background-color: rgba(0,255,0,0.88462549448)\">carcinoma of the head and neck</span> and on 92 controls.</div><br /><div title=\"0.549475669861\">Those who were homozygous for HLA B were more likely to be homozygous for HLA A as well, and more likely to be homozygous for <span title=\"3105\" style=\"background-color: rgba(0,255,0,0.549475669861)\">HLA A</span> as well, and to have more severe <span title=\"DOID:10763\" style=\"background-color: rgba(0,255,0,0.549475669861)\">pre-eclampsia</span>.</div><br /><div title=\"0.887353241444\">Integrated blood plasma levels of LH and FSH and their response to the iv administration of 100 mug synthetic <span title=\"153222\" style=\"background-color: rgba(0,255,0,0.887353241444)\">LRF</span> were studied in 29 normal subjects, 12 women with <span title=\"DOID:11612\" style=\"background-color: rgba(0,255,0,0.887353241444)\">Stein-Leventhal syndrome</span>, 8 subjects with primary gonadal failure, 7 women with Sheehan's syndrome, 20 subjects with pituitary tumors, 10 subjects with idiopathic gonadotropin deficiency and 5 subjects with hypothalamic tumors.</div><br /><div title=\"0.720305204391\">Digestion of <span title=\"DOID:1909\" style=\"background-color: rgba(0,255,0,0.720305204391)\">melanoma</span> cells with <span title=\"4758\" style=\"background-color: rgba(0,255,0,0.720305204391)\">neuraminidase</span> apparently exposed antigens reactive with natural antibodies in rabbit complement because cells so treated had a marked increase in sensitivity to cytolysis.</div><br /><div title=\"0.603636205196\">The draw-a-person (<span title=\"1611\" style=\"background-color: rgba(0,255,0,0.603636205196)\">DAP)</span> and the draw-a-house (DAH) tests were given to <span title=\"DOID:3083\" style=\"background-color: rgba(0,255,0,0.603636205196)\">COLD</span> patients (n = 14), and to patients on chronic renal dialysis (n = 14).</div><br /><div title=\"0.908503890038\">[Value of phosphohexose isomerase (<span title=\"2821\" style=\"background-color: rgba(0,255,0,0.908503890038)\">PHI)</span> determination in <span title=\"DOID:3393\" style=\"background-color: rgba(0,255,0,0.908503890038)\">myocardial infarct]</span>.</div><br /><div title=\"0.640645802021\">The effects of morphine and nalorphine on the plasma 11-hydroxycorticosteroid response to <span title=\"3630\" style=\"background-color: rgba(0,255,0,0.640645802021)\">insulin-induced</span> hypoglycaemia in patients with <span title=\"DOID:7148\" style=\"background-color: rgba(0,255,0,0.640645802021)\">rheumatoid arthritis</span>.</div><br /><div title=\"0.905990064144\">Linkage (although less strong) was also shown for <span title=\"DOID:3312\" style=\"background-color: rgba(0,255,0,0.905990064144)\">bipolar illness</span> and the <span title=\"7499\" style=\"background-color: rgba(0,255,0,0.905990064144)\">Xg blood group</span>.</div><br /><div title=\"0.547297954559\">Capillaries in <span title=\"DOID:1936\" style=\"background-color: rgba(0,255,0,0.547297954559)\">atherosclerotic</span> intima always stained strongly for <span title=\"966\" style=\"background-color: rgba(0,255,0,0.547297954559)\">CD59</span>.</div><br /><div title=\"0.908890128136\">Two series of patients with <span title=\"DOID:3393\" style=\"background-color: rgba(0,255,0,0.908890128136)\">anterior myocardial infarction</span> complicated by right bundle branch block with either left anterior hemiblock (RBBB+LAH) or left posterior hemiblock (<span title=\"3938\" style=\"background-color: rgba(0,255,0,0.908890128136)\">RBBB+LPH)</span>, have been studied.</div><br /><div title=\"0.69367390871\">Serum insulin and <span title=\"2688\" style=\"background-color: rgba(0,255,0,0.69367390871)\">growth hormone</span> response patterns in monozygotic twin siblings of patients with <span title=\"DOID:9744\" style=\"background-color: rgba(0,255,0,0.69367390871)\">juvenile-onset diabetes</span>.</div><br /><div title=\"0.907255649567\">Quantitation of platelet glycoprotein IV (<span title=\"948\" style=\"background-color: rgba(0,255,0,0.907255649567)\">CD36)</span> in healthy subjects and in patients with <span title=\"DOID:2531\" style=\"background-color: rgba(0,255,0,0.907255649567)\">essential thrombocythemia</span> using an immunocapture assay.</div><br /><div title=\"0.873085856438\">Increased <span title=\"11331\" style=\"background-color: rgba(0,255,0,0.873085856438)\">B-AP</span> activities occurred after total hip replacement, in acute or chronic pyelonephritis and in active osteonecrosis and <span title=\"DOID:11476\" style=\"background-color: rgba(0,255,0,0.873085856438)\">osteoporosis</span>.</div><br /><div title=\"0.64659756422\">In a double-blind <span title=\"8743\" style=\"background-color: rgba(0,255,0,0.64659756422)\">trail</span> in 22 patients with mild to moderate essential <span title=\"DOID:10763\" style=\"background-color: rgba(0,255,0,0.64659756422)\">hypertension</span>, indapamide was compared with chlorathiazide and placebo.</div><br /><div title=\"0.877860546112\">The whole blood clotting time, plasma fibrinogen and individual coagulation factors II, V, VII, <span title=\"1351\" style=\"background-color: rgba(0,255,0,0.877860546112)\">VIII</span>, IX, X, XI, and XII were serially measured in 14 patients over a 10-day period following acute <span title=\"DOID:3393\" style=\"background-color: rgba(0,255,0,0.877860546112)\">myocardial infarction</span>.</div><br /><div title=\"0.818411886692\">It has been shown that there is a decrease in the content and activity of three neurospecific proteins (neurospecific enolase--NSE, glial fibrillar acid protein--GFAP and creatine kinase <span title=\"1152\" style=\"background-color: rgba(0,255,0,0.818411886692)\">CK BB)</span> in various structures of the postmortal brain of <span title=\"DOID:5419\" style=\"background-color: rgba(0,255,0,0.818411886692)\">schizophrenic</span> patients and those with senile dementia and Alzheimer's disease.</div><br /><div title=\"0.889781117439\">The <span title=\"6638\" style=\"background-color: rgba(0,255,0,0.889781117439)\">Sm-D(</span>D1) small nuclear ribonucleoprotein (snRNP) polypeptide is a major target of autoantibodies diagnostic for <span title=\"DOID:9074\" style=\"background-color: rgba(0,255,0,0.889781117439)\">systemic lupus erythematosus</span>.</div><br /><div title=\"0.775285542011\">In <span title=\"DOID:11476\" style=\"background-color: rgba(0,255,0,0.775285542011)\">osteoporosis</span> there was an increase in total AP, L-AP, <span title=\"11331\" style=\"background-color: rgba(0,255,0,0.775285542011)\">B-AP</span> and I-AP activities.</div><br /><div title=\"0.820954978466\">[Interrelation between lipid and carbohydrate metabolism in patients following <span title=\"DOID:3393\" style=\"background-color: rgba(0,255,0,0.820954978466)\">myocardial infarct</span> treated at Nalecz  <span title=\"729238\" style=\"background-color: rgba(0,255,0,0.820954978466)\">w-spa]</span>.</div><br /><div title=\"0.832183420658\">We found no marked quantitative or qualitative differences in the distribution of collagen types I, III and IV, laminin, fibronectin or <span title=\"6383\" style=\"background-color: rgba(0,255,0,0.832183420658)\">HSPG</span> in <span title=\"DOID:332\" style=\"background-color: rgba(0,255,0,0.832183420658)\">ALS</span> patients compared to controls.</div><br /><div title=\"0.728232383728\">In this report, we investigated by immunohistochemistry whether <span title=\"966\" style=\"background-color: rgba(0,255,0,0.728232383728)\">CD59</span> was present on cells in human <span title=\"DOID:1936\" style=\"background-color: rgba(0,255,0,0.728232383728)\">atherosclerotic lesions</span> since membranous C5b-9(m) has been found in lesions.</div><br /><div title=\"0.904029369354\">Exposure of EA hyb 926 cells to <span title=\"7124\" style=\"background-color: rgba(0,255,0,0.904029369354)\">TNF</span> (500 U/ml) plus IFN (100 U/ml) for 24 h significantly enhanced their adhesivity for the 51Cr-labeled GLC1 (<span title=\"DOID:1324\" style=\"background-color: rgba(0,255,0,0.904029369354)\">small cell lung carcinoma)</span> TCs.</div><br /><div title=\"0.911076068878\">In the patients with <span title=\"DOID:7148\" style=\"background-color: rgba(0,255,0,0.911076068878)\">rheumatoid arthritis</span> there was a statistically significant correlation between the serum histidine concentration and the following: Westergren sedimentation rate (r=-0.33, P smaller than 10- minus 9), grip strength (r=0.26, P smaller than 10- minus 9), hematocrit (r=0.23, P smaller than 10- minus 9), duration of morning stiffness (r=-0.14, <span title=\"6281\" style=\"background-color: rgba(0,255,0,0.911076068878)\">P=10- minus 5)</span>, walking time (r=-0.13, P=10- minus 4), latex titer of rheumatoid factor (r=-0.11, P=0.001), and the duration of arthritis (r=-0.06, P=0.05).</div><br /><div title=\"0.912571191788\">In the patients with <span title=\"DOID:7148\" style=\"background-color: rgba(0,255,0,0.912571191788)\">rheumatoid arthritis</span> there was a statistically significant correlation between the serum histidine concentration and the following: Westergren sedimentation rate (r=-0.33, P smaller than 10- minus 9), grip strength (r=0.26, P smaller than 10- minus 9), hematocrit (r=0.23, P smaller than 10- minus 9), duration of morning stiffness (r=-0.14, P=10- minus 5), walking time (r=-0.13, <span title=\"6281\" style=\"background-color: rgba(0,255,0,0.912571191788)\">P=10- minus 4)</span>, latex titer of rheumatoid factor (r=-0.11, P=0.001), and the duration of arthritis (r=-0.06, P=0.05).</div><br /><div title=\"0.910671532154\">In the patients with rheumatoid arthritis there was a statistically significant correlation between the serum histidine concentration and the following: Westergren sedimentation rate (r=-0.33, P smaller than 10- minus 9), grip strength (r=0.26, P smaller than 10- minus 9), hematocrit (r=0.23, P smaller than 10- minus 9), duration of morning stiffness (r=-0.14, <span title=\"6281\" style=\"background-color: rgba(0,255,0,0.910671532154)\">P=10- minus 5)</span>, walking time (r=-0.13, P=10- minus 4), latex titer of <span title=\"DOID:7148\" style=\"background-color: rgba(0,255,0,0.910671532154)\">rheumatoid</span> factor (r=-0.11, P=0.001), and the duration of arthritis (r=-0.06, P=0.05).</div><br /><div title=\"0.91259342432\">In the patients with rheumatoid arthritis there was a statistically significant correlation between the serum histidine concentration and the following: Westergren sedimentation rate (r=-0.33, P smaller than 10- minus 9), grip strength (r=0.26, P smaller than 10- minus 9), hematocrit (r=0.23, P smaller than 10- minus 9), duration of morning stiffness (r=-0.14, P=10- minus 5), walking time (r=-0.13, <span title=\"6281\" style=\"background-color: rgba(0,255,0,0.91259342432)\">P=10- minus 4)</span>, latex titer of <span title=\"DOID:7148\" style=\"background-color: rgba(0,255,0,0.91259342432)\">rheumatoid</span> factor (r=-0.11, P=0.001), and the duration of arthritis (r=-0.06, P=0.05).</div><br /><div title=\"0.909862577915\">Gastric acid secretion before and after stimulation with pentagastrin and serum <span title=\"2520\" style=\"background-color: rgba(0,255,0,0.909862577915)\">gastrin</span> response to a test meal were recorded in 9 male controls and in 7 male patients from whom more than 50 cm of the terminal ileum had been resected because of <span title=\"DOID:8778\" style=\"background-color: rgba(0,255,0,0.909862577915)\">Crohn's disease</span>.</div><br /><div title=\"0.893233180046\">Of 73 patients with a history of <span title=\"DOID:0050741\" style=\"background-color: rgba(0,255,0,0.893233180046)\">alcoholism</span> but no other pertient case history or physical examination results, only one had an abnormal <span title=\"2147\" style=\"background-color: rgba(0,255,0,0.893233180046)\">prothrombin</span> time.</div><br /><div title=\"0.631369650364\">Sera from normal healthy controls showed a higher proportion of LDH-H form (72%) while <span title=\"DOID:1024\" style=\"background-color: rgba(0,255,0,0.631369650364)\">lepromatous leprosy</span> patient's sera exhibited a higher proportion of <span title=\"3939\" style=\"background-color: rgba(0,255,0,0.631369650364)\">LDH-M</span> form (55%).</div><br /><div title=\"0.923512458801\">Expression of <span title=\"5155\" style=\"background-color: rgba(0,255,0,0.923512458801)\">c-sis/platelet-derived</span> growth factor B, insulin-like growth factor I, and transforming growth factor alpha messenger RNAs and their respective receptor messenger RNAs in primary human <span title=\"DOID:10534\" style=\"background-color: rgba(0,255,0,0.923512458801)\">gastric carcinomas</span>: in vivo studies with in situ hybridization and immunocytochemistry.</div><br /><div title=\"0.851859331131\">Here we demonstrate that <span title=\"3375\" style=\"background-color: rgba(0,255,0,0.851859331131)\">amylin</span> has a hypocalcemic effect in patients with <span title=\"DOID:5408\" style=\"background-color: rgba(0,255,0,0.851859331131)\">Paget's disease of bone</span>.</div><br /><div title=\"0.651185810566\">Interested in the effect of IL-1 on early <span title=\"DOID:1936\" style=\"background-color: rgba(0,255,0,0.651185810566)\">atherosclerotic lesion</span> formation, we have characterized the <span title=\"3552\" style=\"background-color: rgba(0,255,0,0.651185810566)\">IL-1</span> receptors on human aortic endothelial cells (HAEC).</div><br /><div title=\"0.919509589672\">We were unable to confirm previous observations of a <span title=\"6957\" style=\"background-color: rgba(0,255,0,0.919509589672)\">TCR beta</span> association with <span title=\"DOID:7148\" style=\"background-color: rgba(0,255,0,0.919509589672)\">RA</span> even after stratifying our study and control populations by HLA type.</div><br /><div title=\"0.824844777584\">A wide range of expression of each gene was found within each <span title=\"2187\" style=\"background-color: rgba(0,255,0,0.824844777584)\">FAB</span> type of <span title=\"DOID:2531\" style=\"background-color: rgba(0,255,0,0.824844777584)\">AML</span>.</div><br /><div title=\"0.867935240269\">The <span title=\"DOID:2394\" style=\"background-color: rgba(0,255,0,0.867935240269)\">ovarian tumor</span> was immunohistochemically reactive for neuron-specific enolase, chromogranin, <span title=\"6855\" style=\"background-color: rgba(0,255,0,0.867935240269)\">synaptophysin</span>, and serotonin, but did not stain for calcitonin.</div><br /><div title=\"0.918832063675\">In this study, we investigated the effects of calcitonin on the growth of human <span title=\"DOID:10534\" style=\"background-color: rgba(0,255,0,0.918832063675)\">gastric carcinoma</span> cell line KATO III in comparison with those of <span title=\"796\" style=\"background-color: rgba(0,255,0,0.918832063675)\">calcitonin gene-related peptide</span> (CGRP).</div><br /><div title=\"0.942778646946\">In this study, we investigated the effects of calcitonin on the growth of human <span title=\"DOID:10534\" style=\"background-color: rgba(0,255,0,0.942778646946)\">gastric carcinoma</span> cell line KATO III in comparison with those of calcitonin gene-related peptide (<span title=\"796\" style=\"background-color: rgba(0,255,0,0.942778646946)\">CGRP)</span>.</div><br /><div title=\"0.852204859257\">Our results demonstrate that <span title=\"DOID:2531\" style=\"background-color: rgba(0,255,0,0.852204859257)\">HD</span> derived cell lines produce a variety of cytokines, such as IL1 alpha, IL4, IL5, IL6, IL8, TNF alpha, <span title=\"4049\" style=\"background-color: rgba(0,255,0,0.852204859257)\">TNF beta</span> and GM-CSF but not IL1 beta, IL2, IL3 and G-CSF.</div><br /><div title=\"0.908495128155\">Plasma prorenin and <span title=\"5972\" style=\"background-color: rgba(0,255,0,0.908495128155)\">renin</span> levels in <span title=\"DOID:9352\" style=\"background-color: rgba(0,255,0,0.908495128155)\">non-insulin-dependent diabetes mellitus</span>.</div><br /><div title=\"0.905257642269\">The majority of cases (76%) showed the <span title=\"8506\" style=\"background-color: rgba(0,255,0,0.905257642269)\">p190</span> gene subtype similar to <span title=\"DOID:2531\" style=\"background-color: rgba(0,255,0,0.905257642269)\">pediatric ALL</span>; the BCR-ABL-positive cases displayed a more homogeneous immunophenotype than the BCR-ABL-negative cases and were predominantly CALLA positive (86%) and B-cell surface antigen positive (82%).</div><br /><div title=\"0.841023921967\">The most common IP profile for <span title=\"DOID:1319\" style=\"background-color: rgba(0,255,0,0.841023921967)\">CP tumors</span> (<span title=\"3875\" style=\"background-color: rgba(0,255,0,0.841023921967)\">cytokeratin 18</span>+, PI-153/3+, Thy-1+, UJ 223.8+, and GFAP+ and UJ13A-, UJ 127.11-, and NF-L-) is discussed in the context of the current knowledge of the ontogenetic origin of the CP.</div><br /><div title=\"0.905248343945\">Numerous 'candidate genes' for <span title=\"DOID:0050741\" style=\"background-color: rgba(0,255,0,0.905248343945)\">alcoholism</span> have been suggested including the alcohol metabolizing enzymes, alcohol <span title=\"10327\" style=\"background-color: rgba(0,255,0,0.905248343945)\">dehydrogenase</span> (ADH) and aldehyde dehydrogenase (ALDH).</div><br /><div title=\"0.909684002399\">Specific binding of <span title=\"301\" style=\"background-color: rgba(0,255,0,0.909684002399)\">lipocortin-1</span> (annexin I) to monocytes and neutrophils is decreased in <span title=\"DOID:7148\" style=\"background-color: rgba(0,255,0,0.909684002399)\">rheumatoid arthritis</span>.</div><br /><div title=\"0.867956697941\">[Complex characteristics of the alterations of oncogenes <span title=\"2064\" style=\"background-color: rgba(0,255,0,0.867956697941)\">HER-2</span>/ERBB-2, HER-1/ERBB-1, HRAS-1, C-MYC and antioncogenes p53, RB1, as well as deletions of loci of chromosome 17 in <span title=\"DOID:219\" style=\"background-color: rgba(0,255,0,0.867956697941)\">colon carcinoma]</span>.</div><br /><div title=\"0.906922519207\">[Complex characteristics of the alterations of oncogenes HER-2/<span title=\"2064\" style=\"background-color: rgba(0,255,0,0.906922519207)\">ERBB-2</span>, HER-1/ERBB-1, HRAS-1, C-MYC and antioncogenes p53, RB1, as well as deletions of loci of chromosome 17 in <span title=\"DOID:219\" style=\"background-color: rgba(0,255,0,0.906922519207)\">colon carcinoma]</span>.</div><br /><div title=\"0.767553031445\">C33 antigen recognized by monoclonal antibodies inhibitory to human <span title=\"DOID:2531\" style=\"background-color: rgba(0,255,0,0.767553031445)\">T cell leukemia virus type 1-induced</span> syncytium formation is a member of a new family of transmembrane proteins including CD9, CD37, <span title=\"963\" style=\"background-color: rgba(0,255,0,0.767553031445)\">CD53</span>, and CD63.</div><br /><div title=\"0.907420516014\">These findings suggest that <span title=\"4353\" style=\"background-color: rgba(0,255,0,0.907420516014)\">myeloperoxidase</span> is the major enzyme involved in the formation of reactive metabolites by leukocytes, a pathway that we propose may be responsible for procainamide-induced <span title=\"DOID:9074\" style=\"background-color: rgba(0,255,0,0.907420516014)\">lupus</span> and agranulocytosis.</div><br /><div title=\"0.893459022045\">Our results suggest that pretreating <span title=\"DOID:1192\" style=\"background-color: rgba(0,255,0,0.893459022045)\">neuroblastoma</span> patients with <span title=\"3458\" style=\"background-color: rgba(0,255,0,0.893459022045)\">IFN-gamma</span> before MIBG administration may enhance the efficacy of both biologically targeted radioimaging and therapy of this tumor.</div><br /><div title=\"0.902696609497\">CSF <span title=\"7124\" style=\"background-color: rgba(0,255,0,0.902696609497)\">TNF alpha</span> was detected only in <span title=\"DOID:3565\" style=\"background-color: rgba(0,255,0,0.902696609497)\">NM</span> from cases of malignant melanoma.</div><br /><div title=\"0.80875736475\">[Association studies in cancerology: the example of gene <span title=\"4610\" style=\"background-color: rgba(0,255,0,0.80875736475)\">L-myc</span> polymorphism associated with the incidence of pulmonary metastases in <span title=\"DOID:1612\" style=\"background-color: rgba(0,255,0,0.80875736475)\">breast cancers]</span>.</div><br /><div title=\"0.913154482841\">Intestinal alpha 1-antitrypsin (<span title=\"5265\" style=\"background-color: rgba(0,255,0,0.913154482841)\">alpha 1-AT)</span> clearance has been shown a reliable index of intestinal inflammatory activity in <span title=\"DOID:8778\" style=\"background-color: rgba(0,255,0,0.913154482841)\">Crohn's disease</span> (CD).</div><br /><div title=\"0.912154614925\">Intestinal alpha 1-antitrypsin (<span title=\"5265\" style=\"background-color: rgba(0,255,0,0.912154614925)\">alpha 1-AT)</span> clearance has been shown a reliable index of intestinal inflammatory activity in Crohn's disease (<span title=\"DOID:8778\" style=\"background-color: rgba(0,255,0,0.912154614925)\">CD)</span>.</div><br /><div title=\"0.838317513466\">The intrathecal immune response in neoplastic meningitis (<span title=\"DOID:3565\" style=\"background-color: rgba(0,255,0,0.838317513466)\">NM)</span> was studied by quantitation of immune parameters such as immunoglobulin G (IgG); IgM; interleukins (IL) 1, 2, 4, and 6; soluble IL-2 receptors (sIL-2R); interferon gamma (IFNy); tumor necrosis factor-alpha (<span title=\"7124\" style=\"background-color: rgba(0,255,0,0.838317513466)\">TNF alpha)</span>; and three tumor markers, carcinoembryonic antigen (CEA), alpha-fetoprotein (AFP), and fibronectin (FN), in 47 paired cerebrospinal fluid (CSF) and serum samples from patients with NM from different carcinomas, malignant melanoma, and lymphoma.</div><br /><div title=\"0.823368370533\">The intrathecal immune response in neoplastic meningitis (NM) was studied by quantitation of immune parameters such as immunoglobulin G (IgG); IgM; interleukins (IL) 1, 2, 4, and 6; soluble IL-2 receptors (sIL-2R); interferon gamma (IFNy); tumor necrosis factor-alpha (<span title=\"7124\" style=\"background-color: rgba(0,255,0,0.823368370533)\">TNF alpha)</span>; and three tumor markers, carcinoembryonic antigen (CEA), alpha-fetoprotein (AFP), and fibronectin (FN), in 47 paired cerebrospinal fluid (CSF) and serum samples from patients with <span title=\"DOID:3565\" style=\"background-color: rgba(0,255,0,0.823368370533)\">NM</span> from different carcinomas, malignant melanoma, and lymphoma.</div><br /><div title=\"0.92590790987\">The host cell of <span title=\"59271\" style=\"background-color: rgba(0,255,0,0.92590790987)\">B19</span> is a specialised progenitor of mature red cells: impairment of the function of this cell by B19 may cause profound <span title=\"DOID:2355\" style=\"background-color: rgba(0,255,0,0.92590790987)\">anaemia</span>.</div><br /><div title=\"0.927897453308\">The host cell of B19 is a specialised progenitor of mature red cells: impairment of the function of this cell by <span title=\"59271\" style=\"background-color: rgba(0,255,0,0.927897453308)\">B19</span> may cause profound <span title=\"DOID:2355\" style=\"background-color: rgba(0,255,0,0.927897453308)\">anaemia</span>.</div><br /><div title=\"0.808342456818\">METHODS: Eight cases each of multiple jejunoileal carcinoids and <span title=\"DOID:11239\" style=\"background-color: rgba(0,255,0,0.808342456818)\">appendiceal carcinoids</span> together with their respective age-matched and sex-matched controls were stained with silver stains, <span title=\"1113\" style=\"background-color: rgba(0,255,0,0.808342456818)\">chromogranin A</span>, serotonin, and S-100.</div><br /><div title=\"0.906275749207\">The presence in plasma from <span title=\"DOID:2355\" style=\"background-color: rgba(0,255,0,0.906275749207)\">PNH</span> patients of such a secreted, hydrophilic form of <span title=\"5329\" style=\"background-color: rgba(0,255,0,0.906275749207)\">uPAR</span> lends support to the hypothesis that the lesion underlying the PNH disorder resides either in glycolipid biosynthesis or in the function of an as-yet-unidentified transamidating enzyme assumed to cleave and assemble the truncated uPAR with the preformed glycolipid moiety.</div><br /><div title=\"0.905120491982\">The presence in plasma from <span title=\"DOID:2355\" style=\"background-color: rgba(0,255,0,0.905120491982)\">PNH</span> patients of such a secreted, hydrophilic form of uPAR lends support to the hypothesis that the lesion underlying the PNH disorder resides either in glycolipid biosynthesis or in the function of an as-yet-unidentified transamidating enzyme assumed to cleave and assemble the truncated <span title=\"5329\" style=\"background-color: rgba(0,255,0,0.905120491982)\">uPAR</span> with the preformed glycolipid moiety.</div><br /><div title=\"0.914722383022\">The presence in plasma from PNH patients of such a secreted, hydrophilic form of <span title=\"5329\" style=\"background-color: rgba(0,255,0,0.914722383022)\">uPAR</span> lends support to the hypothesis that the lesion underlying the <span title=\"DOID:2355\" style=\"background-color: rgba(0,255,0,0.914722383022)\">PNH disorder</span> resides either in glycolipid biosynthesis or in the function of an as-yet-unidentified transamidating enzyme assumed to cleave and assemble the truncated uPAR with the preformed glycolipid moiety.</div><br /><div title=\"0.914350271225\">The presence in plasma from PNH patients of such a secreted, hydrophilic form of uPAR lends support to the hypothesis that the lesion underlying the <span title=\"DOID:2355\" style=\"background-color: rgba(0,255,0,0.914350271225)\">PNH disorder</span> resides either in glycolipid biosynthesis or in the function of an as-yet-unidentified transamidating enzyme assumed to cleave and assemble the truncated <span title=\"5329\" style=\"background-color: rgba(0,255,0,0.914350271225)\">uPAR</span> with the preformed glycolipid moiety.</div><br /><div title=\"0.902051508427\">In contrast, <span title=\"3383\" style=\"background-color: rgba(0,255,0,0.902051508427)\">ICAM-1</span> expression was detected in the thyrocytes of 5/11 (45%) benign nodules and of 8/12 (67%) <span title=\"DOID:1781\" style=\"background-color: rgba(0,255,0,0.902051508427)\">thyroid carcinomas</span> in which it was sometimes strong.</div><br /><div title=\"0.864222705364\">Currently available markers such as the serum gamma-glutamyl transpeptidase (<span title=\"92086\" style=\"background-color: rgba(0,255,0,0.864222705364)\">GGT)</span>, serum transaminases, and the mean corpuscular volume (MCV) lack sufficient sensitivity and specificity to be used for screening of <span title=\"DOID:0050741\" style=\"background-color: rgba(0,255,0,0.864222705364)\">alcoholism</span> in ambulatory patients.</div><br /><div title=\"0.842450797558\"><span title=\"1950\" style=\"background-color: rgba(0,255,0,0.842450797558)\">Epidermal growth factor</span> and the related peptide transforming growth factor alpha have been implicated in the stimulation of <span title=\"DOID:10534\" style=\"background-color: rgba(0,255,0,0.842450797558)\">gastric mucosal proliferation</span>.</div><br />\n",
       "</body>\n",
       "</html>\n"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "with open(\"html/candidate_viewer.html\", 'r') as f:\n",
    "    display(HTML(f.read().format(html_string)))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Write Results to CSV"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "model_marginals.to_csv(\"stratified_data/lstm_disease_gene_holdout/test_marginals.csv\", index=False)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 2",
   "language": "python",
   "name": "python2"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 2
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython2",
   "version": "2.7.13"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
